Kennesaw, GA—Deerland Probiotics & Enzymes announced that it has completed the integration of Denmark-based Bifodan A/S. As WholeFoods previously reported, Bidofan was acquired in 2019. A press release from Deerland shares that the two companies now operate as one global entity under the Deerland brand, and that customers of both now can have full access to an expanded portfolio of science-backed probiotic, prebiotic and enzyme technologies through branded ingredients, customized formulations, and ready-to-market turnkey solutions in more than 40 countries. This enlarged global footprint, Deerland added, strengthens the company’s value proposition.
“We are excited to unleash the power of two organizations, now operating as one elite global solutions provider,” said Scott Ravech, CEO of Deerland, in the release. “Together, we are one step closer to achieving our vision of all people of all cultures benefiting from our enzyme, probiotic and prebiotic health products and science-backed technologies.”
As part of the integration process, Deerland announced, sales and marketing teams from the two companies addressed how the combined company would collaborate with customers to develop innovative and proprietary solutions. Additionally, the global research and development teams worked to ensure that each product offering would be supported with sound clinical science, and the manufacturing teams optimized production in the company’s four TGA and cGMP certified facilities around the globe.